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IntroductIon
one of the features of asthma is persistent pul‑
monary inflammation with increased numbers of 
activated t‑lymphocytes, eosinophils and macro‑
phages/monocytes, and resident tissue cells. these 
cells play a role in establishment and maintenance 
of the chronic inflammatory process by releasing a 
wide repertoire of cytokines, chemokines, and other 
proinflammatory mediators. there is increasing 
evidence that reactive oxygen and nitrogen species 
are also important mediators of the inflammatory 
process, providing a cellular mechanism that links 
oxidative stress and chronic inflammation. oxidants 
are a well‑characterized source of cellular injury at 
multiple levels, and they are believed to produce 
many of the features typical of asthma (c a r a m o r i 
and P a p i , 2004). on the other hand, as intracellu‑
lar molecular messengers, they regulate specific and 
redox‑dependent signaling pathways modulating 
the expression of a variety of genes, among which 
are the genes coding for cytokines (M o r e l  and 
B a r o u k i , 1999).
Binding of a ligand to the glucocorticoid recep‑
tor (Gr) is an important step in regulation and 
modulation of glucocorticoid signal transduction. 
upon interaction with a steroid, the Gr becomes 
activated to a form that can interact with specific 
regulatory dnA elements in the promoter region 
of glucocorticoid‑sensitive genes, thereby modify‑
ing their transcription. Alternatively, the activated 
receptor can exert its transactivation or transrepres‑
sion activity by interacting with other regulatory 
proteins, thus mediating most of the anti‑inflam‑
matory and immunosuppressive actions of gluco‑
corticoid hormones. Extensive studies have shown 
that the Gr is subject to redox modulation in vitro 
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(S i l v a  and c i d l o w s k i , 1989; M e s h i n c h i  et 
al., 1990), as well as in vivo (M a k i n o  et al., 1996; 
G a l i g n i a n a  et al., 1999). By virtue of being a 
redox‑sensitive transcription factor, the Gr is a 
potential target through which reactive species can 
modulate the expression of glucocorticoid‑depen‑
dant genes especially in asthma, where reactive 
oxygen species are important factors of the dis‑
ease pathogenesis (c a r a m o r i  and P a p i , 2004). 
Additionally, oxidative stress and proinflammatory 
mediators can enhance the inflammatory response 
and modulate corticosteroid function by repression 
of HdAc2 activity (I t o  et al., 2004). Attenuation of 
this activity was found to be associated with nitra‑
tion of the enzyme’s tyrosine residues, which can be 
provoked by H2o2 or peroxynitrite.
In this study, we performed initial experiments 
to test a hypothesis that the pathogenesis and/or 
maintenance of the chronic disease in asthmatic 
patients can be attributed to defects in Gr function 
possibly resulting from the action of oxidants. to 
that end, we conducted a series of ex vivo treatments 
of peripheral lymphocytes with oxidizing agents and 
compared resulting Gr functional alterations with 
the alterations previously registered in asthmatic 
patients with mild and moderate asthma (P e r i š i ć 
et al., 2008). 
MAtErIAlS And MEtHodS
Blood sampling and cell isolation
Blood samples were obtained from healthy adult 
volunteers by venipuncture. Blood was collected 
in heparinized tubes (25 u/ml), and peripheral 
blood mononuclear cells (PBMcs) were isolated 
within one hour from blood drawing. to isolate the 
cells, blood was diluted with an equal volume of 
phosphate‑buffered saline (PBS) (0.14 mmol/l nacl, 
2.7 mmol/l kcl, 1.5 mmol/l kH2Po4, 6.5 mmol/l 
na2HPo4; pH 7.2) and subjected to density gradient 
centrifugation over Ficoll‑Paque Plus (Amersham 
Biosciences) at 380 x g for 30 min at 23ºc. the cells 
were thoroughly washed with PBS and resuspended 
in rPMI‑1640 medium (Gibco/Invitrogen) supple‑
mented with 2 mM glutamine, 25 mM HEPES, 
and 10% heat‑inactivated fetal bovine serum (FBS) 
(Gibco/Invitrogen). cell viability, evaluated by the 
trypan Blue dye exclusion method, was always 
found to be greater than 95%. the PBMcs that were 
not used immediately were rapidly frozen in liquid 
nitrogen.
Hormone binding assay
the cell suspension was adjusted to a final density 
of 5x106 cells/ml. Aliquots of mononuclear cells, 
containing 1x106 cells each, were incubated with 
[3H]dexamethasone (Amersham Biosciences, spec. 
act. 34 to 40 ci/mmol) at five or six different concen‑
trations (depending on PBMc yield) ranging from 5 
to 120 nM in triplicate in the absence or presence of 
a 100‑fold molar excess of unlabeled dexamethasone 
(Sigma chemical co., Mo, uSA) to determine total 
and nonspecific binding, respectively. After 2 h of 
incubation in a water bath at 37ºc, all tubes were 
placed on ice and the reaction stopped by adding 1 
ml of ice‑cold PBS. Following three cycles of washing 
at 4ºc with PBS and centrifugation at 1000 x g for 
5 min at 4ºc, the final pellets were resuspended in 
PBS and transferred to 3 ml of a scintillation cocktail 
(Ecoscint H, national diagnostic Inc). radioactivity 
measurements were performed in a rackbeta scin‑
tillation counter (lkB) with approximately 50% effi‑
ciency for tritium. Specific binding was calculated 
by subtracting the nonspecific from total binding at 
each dexamethasone concentration. to assess inter‑
assay variation, repeated measurements were per‑
formed on different occasions. For determination of 
the Gr number, an intra‑individual variation of 18% 
was registered, while the coefficient of variation for 
its hormone–binding affinity was found to be 22%, 
these data being in agreement with existing reports 
(H e a r i n g  et al., 1999; H a g e n d o r f  et al., 2005). 
the number of receptor sites per cell and apparent 
dissociation constant (kd) were calculated using 
computer‑assisted nonlinear regression curve fitting 
procedure and assuming competitive binding to one 
class of binding sites.
Treatment of PBMCs with oxidizing agents
Mononuclear cells were isolated and resuspended in 
rPMI‑1640 medium containing 2 mM glutamine, 
25 mM HEPES, and 10% heat‑inactivated FBS. 
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the cells were incubated in the presence of 1 mM 
3‑morpholinosydnonimine hydrochloride (SIn‑1, 
Sigma chemical co), 1 mM S‑nitroso‑n‑acetylpen‑
icillamine (SnAP, Sigma chemical co.), or 1 mM 
H2o2 (Sigma chemical co.) for 6 h at 37ºc. the 
first of these agents (SIn‑1) releases superoxide 
anion (o2ˉ) and nitrogen monoxide (no) in equi‑
molar quantities, thereby producing peroxynitrite 
anion (ono2¯), whereas SnAP is a pure no donor. 
treatment with SIn‑1 was performed according to 
M a r t i n ‑ r o m e r o  et al. (2004). Briefly, in order 
to obtain a steady‑state concentration of short‑lived 
ono2¯ during 6 h, we applied sequential SIn‑1 
pulses to simulate chronic exposure. the initial 
90 mM stock solution of SIn‑1 was freshly prepared 
in acidic buffer (pH 5.0) and kept on ice in the 
dark.
After the treatment, the medium was replaced 
by fresh medium and cell viability was estimated. 
An aliquot of the mononuclear cell suspension 
from each treatment was stored in liquid nitrogen 
for subsequent analysis. the rest was subjected to 
radioligand‑binding assay and analyzed for Gr 
binding parameters.
Cellular protein extraction
For protein extraction, cellular pellets (1×106 cells) 
were resuspended in 15 μl of ice cold hypotonic 
lysis buffer (50 mmol/l nacl, 5% glycerol, 0.5% 
triton X‑100, 2 mmol/l ethylenediaminetetraacetic 
acid, and 50 mmol/l tris; pH 7.5) supplemented 
with a complete protease inhibitor cocktail (roche 
diagnostics GmbH). Following incubation on ice 
for 15 min and two freeze/thaw cycles, the lyzate 
was centrifuged at 13,000 x g for 15 min at 4ºc. the 
supernatants, referred to as whole cell extracts, were 
stored in small portions at ‑75ºc. Protein concentra‑
tion ranged from 3 to 6 μg/μl.
Western blotting
the proteins were reduced and denatured by 
5‑min treatment at 95ºc with a buffer contain‑
ing 62.5 μM tris (pH 6.8), 2% SdS, 10% glycerol, 
5% β‑mercaptoethanol, and 0.0075% bromphenol 
blue. the proteins (70 μg per lane) were resolved 
on 7.5% SdS‑PA gel, together with protein molecu‑     
lar mass standards (29‑205 kda, Sigma chemical  
co.). After overnight transfer, PvdF membranes      
(Hybond‑P, Amersham Biosciences) were incubated    
in a blocking buffer containing 2.5% nonfat dry milk 
in PBS (pH 7.2) for 1.5 h at room temperature. the 
Gr was detected using two different anti‑Gr polyclo‑
nal antibodies: PA1‑511A (1:1000 dilution; Affinity 
Bioreagents, Golden, co) and Gr M‑20 (1:500 dilu‑
tion; Santa cruz Biotechnology, Santa cruz, cA). 
the former antibody, herein designated Ab1, was 
raised against an immunizing peptide correspond‑
ing to amino acid residues 346‑367 of the human 
Gr (c i d l o w s k i  et al., 1990). the latter anti‑
body, designated Ab2, was raised against n‑terminal 
amino acids of murine Gr. After three cycles 
of washing with PBS containing 0.1% tween 20, 
the membranes were incubated for 1 h with alka‑
line phosphatase‑conjugated secondary antibody. 
the immunoreactive protein bands were visual‑
ized on StorM (Amersham Pharmacia Biotech 
uk limited, England) by an enhanced chemif‑
luorescent method (EcF, Amersham Biosciences).  
the membranes were reprobed with mouse mono‑
clonal anti‑β‑actin antibody (1:8000 dilution; Sigma      
chemical co.) to verify equal protein load in each 
lane. Since protein nitration was used as a measure 
of ono2¯ formation, monoclonal anti‑nitrotyrosine 
antibody (1:500; upstate Biotechnology Inc., lake     
Placid, nY) was also used. For positive control,       
BSA at 10 mg/ml in PBS (pH 7.4) was incubated 
with 10 mM SIn‑1 for 2 h at 37ºc. relative inte‑
grated optical density of immunoreactive bands was 
measured using Image Quant software (Amersham 
Biosciences limited, uk) and the results expressed 
in arbitrary units (Au).
Statistical analyses
the relative levels of Gr protein and its functional 
parameters before and after the treatments were 
compared by the nonparametric kruskal‑Wallis 
test, followed by an appropriate post hoc test. 
Between‑group differences were analyzed with the 
Mann‑Whitney u‑test, or with the t‑test, where 
appropriate. A two‑tailed p value of less than 0.05 
was considered significant. Statistical comparisons 
were carried out using GraphPad Prism, version 4.0 
(GraphPad Prism Software Inc., San diego, cA).
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Fig. 1. Effect of oxidizing agents on GR binding parameters in 
PBMCs of healthy adult donors. (A) Representative saturation 
curves of [3H]dexamethasone binding in untreated and treated 
cells. Cumulative quantitative data on (B) GR binding affinity 
and (C) the number of  hormone-binding sites per cell in un-
treated and in cells treated with 1 mM SIN 1, 1 mM SNAP, or 1 
mM H2O2. The results are expressed as means ± SEM for two 
independent experiments. **: p<0.005 compared to untreated 
control (t test).
rESultS
to examine the effects of several different oxidiz‑
ing agents on Gr ligand–binding parameters in 
PBMcs, a set of experiments was performed using 
freshly isolated PBMcs obtained from the blood of 
healthy adult donors. Pilot experiments were car‑
ried out to determine optimal conditions for cell 
treatment that produced no effect on viability of 
the cells, as measured by the trypan Blue exclu‑
sion method. cells were treated with 1 mM SIn‑1, 
1 mM SnAP, and 1 mM H2o2 and subsequently 
assayed for [3H]dexamethasone binding. Figure 1A 
shows [3H]dexamethasone binding curves before 
and after treatment of PBMcs with oxidizing agents. 
the equilibrium dissociation constant (kd) of the 
hormone‑receptor interaction, calculated from the 
binding curves by computer‑assisted analysis, was 
increased by treatment with SIn‑1 (57.3 ± 5.9 nM; 
p=0.003) and H2o2 (82.3 ± 10.0 nM; p=0.003), but 
remained unchanged after treatment with SnAP 
(12.6 ± 1.3 nM) as compared to kd in untreated 
PBMcs (10.3 ± 2.4 nM) (Fig. 1B). on the premise 
that kd is inversely proportional to the receptor’s 
affinity for the hormone, the results demonstrate 
that  treatment with SIn‑1 and H2o2 led to a 
decrease of the receptor’s ligand‑binding affinity, 
while SnAP left it unchanged. Furthermore, after 
treatment with SIn‑1 the number of dexametha‑
sone‑binding sites per cell was severely decreased 
(606 ± 127; p=0.007) in comparison with untreated 
cells (4125 ± 852). In contrast, treatment with H2o2 
caused an elevation in the number of receptor sites 
in PBMcs (12556 ± 1174; p=0.006), whereas treat‑
ment with SnAP did not affect it (4010 ± 511, n=2) 
(Fig. 1c).
When Western blot analysis of Gr bands was 
done using Ab1 antibody, a specific pattern of the 
Gr bands was obtained both before and after treat‑
ment with oxidants. In untreated cells, in addition 
to a rather weak 94‑kda band, corresponding to the 
full‑length Gr, immunospecific bands migrating 
at approximately 60, 55, 50, 45, and 29 kda, cor‑
responding to truncated Gr molecules, were also 
detected (Fig. 2A, upper left panel). A similar pattern 
of immunoreactive bands was obtained with PBMcs 
of another blood donor (Fig. 2A, upper right panel). 
treatment with SIn‑1 reduced the intensity of all 
immunoreactive protein bands, especially those 
with lower molecular masses. the pattern obtained 
after treatment with SnAP resembled that found in 
PBMc extracts after treatment with SIn‑1. on the 
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other hand, H2o2 treatment yielded a prominent 
band migrating at around 60 kda, while reactivity 
of the 50‑ and 29‑kda bands was comparable to 
that in untreated cells. After the blots were reprobed 
with Ab2, the 94 kda band became much more 
pronounced in all samples (Fig. 2A, middle pan‑
els), while the lower‑molecular‑mass isoforms were 
not detected. Analysis of Gr/actin ratios revealed 
that SIn‑1 and H2o2 treatments produced a slight 
decrease and an increase, respectively in intensity 
of the 94‑kda band, although these differences were 
not statistically significant (Fig. 2B).
In principle, changes of Gr binding activity 
such as those registered in our study upon treat‑
ment of PBMc extracts with SIn‑1, that is decrease 
Fig. 2. Effect of oxidizing agents on GR protein level in PBMCs of healthy adult donors. (A) Representative 
immunoblots of GR expression in cells of two healthy adult donors before and after the treatment with 1 mM 
SIN 1, 1 mM SNAP, or 1 mM H2O2 obtained with antibody Ab1 (upper panels) and antibody Ab2 (middle 
panels). Actin (lower panels) was used as an equal load control. (B) Cumulative quantitative data on the 
relative level of full-length GR (94-kDa) bands obtained with Ab2. The integrated optical densities of bands, 
determined with ImageQuant software, were normalized to actin. Results are expressed as means ± SEM for 
two independent determinations.
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Fig. 1. Western blot analysis of nitrotyrosine modified proteins 
in cellular extracts of mononuclear cells. Bovine serum albumin 
treated with 10 mM SIN 1 for 2 h at 37ºC in PBS, pH 7.4, was 
used as a positive control (lane 1). Nitrotyrosine was not detect-
ed in untreated PMBCs of healthy adult donors (lane 3) or cells 
treated with 1 mM SIN 1 for 6 h at 37ºC (lane 4). The positions 
of molecular mass reference proteins are shown in lane 2.
in both Gr number and hormone–binding affinity, 
could be a consequence of the receptor’s covalent 
modification. Since SIn‑1 is known to release no 
and o2¯, which react to produce a powerful oxidant 
and nitrating agent, ono2¯, we used an antibody 
raised against the protein nitrotyrosine to check for 
nitration of proteins, specifically the Gr, upon treat‑
ment with SIn‑1. However, in our experiment no 
nitrated proteins in SIn‑1–treated cellular extracts 
of PBMcs were detected, while BSA, used as a posi‑
tive control, was succesfully nitrated by the same 
treatment (Fig. 3).
dIScuSSIon
In the present study, treatment of PBMcs of healthy 
adult blood donors with H2o2 was found to induce 
alterations of Gr binding parameters, including 
decrease in the receptor’s affinity for the ligand and 
increase in the number of receptor sites per cell. 
these alterations were similar to those observed in 
PBMcs isolated from the blood of pediatric patients 
suffering from moderate asthma, which in that 
respect differed from mild asthmatics and healthy 
controls (P e r i š i ć  et al., 2008). Moreover, the pat‑
tern of Gr protein bands obtained after treatment 
of PBMcs with H2o2 also resembled that observed 
in PBMcs of moderate asthmatics (P e r i š i ć  et 
al., unpublished data). the similarity between the 
Gr alterations produced by ex vivo treatment of 
PBMcs with H2o2 and those observed in PBMcs of 
moderate asthmatics suggests that pediatric moder‑
ate asthma might be associated with structural and 
functional modifications of the Gr that are likely to 
result from H2o2‑mediated oxidative stress.
there is considerable evidence that some 
post‑translational modifications of the receptor can 
influence its ability to bind hormone. oxidizing con‑
ditions such as those created by H2o2 treatment were 
previously shown to promote formation of intramo‑
lecular disulfide bonds, which alter the structure 
(S i l v a  and c i d l o w s k i , 1989; M e s h i n c h i  et 
al., 1990) and/or reversibly inactivate steroid‑bind‑
ing activity (M e s h i n c h i  et al., 1990; M a k i n o 
et al., 1996) of the receptor. In this study, we found 
that treatment with H2o2 can induce a considerable 
decrease in ligand‑binding affinity (i.e., increase of 
kd), accompanied by increase in both the number 
of hormone‑binding sites and levels of the Gr pro‑
tein in PBMcs from healthy donors. on the other 
hand, SnAP, as a no donor, did not provoke any 
changes of Gr function, whereas SIn‑1, being a 
ono2¯ donor, dramatically reduced both Gr bind‑
ing parameters. the differences in effects of the 
oxidizing agents applied can probably be ascribed 
to different chemical modifications of the recep‑
tor. In contrast to studies presenting evidence for 
distinct effects of no‑donating compounds on Gr 
affinity for the hormone in vivo (G a l i g n i a n a  et 
al., 1999; P a u l ‑ c l a r k  et al., 2003), influence of 
the ono2¯ donor SIn‑1 on Gr binding properties 
has not yet been investigated. It has been experi‑
mentally confirmed and generally accepted that 
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both in oxygenated solution and in physiological 
conditions, SIn‑1 releases no and o2¯. the product 
of their simultaneous reaction is ono2¯, a potent 
oxidizing agent that has been suggested to play a 
role in several pathological conditions, including 
asthma (S a l e h  et al., 1998). Although the forma‑
tion of nitrotyrosine is considered to be an indica‑
tor of ono2¯ presence and activity, in our study 
anti‑nitrotyrosine antibody failed to recognize cor‑
responding epitopes in cellular extracts of PBMcs 
treated with SIn‑1. this result suggests that the 
herein observed decrease in Gr number and its 
hormone‑binding affinity was not a consequence of 
Gr nitration, or that these changes were indirectly 
induced by SIn‑1 treatment. Additionally, it is also 
possible that the level of Gr nitration was too low to 
be detected by immunoblotting, or that intracellular 
conditions hampered ono2¯ formation, prompting 
SIn‑1 to behave more like a no donor (S i n g h  et 
al., 1999). thus, the precise mechanisms governing 
the observed functional modifications and changes 
of Gr expression in mononuclear cells, including 
delineation between direct and indirect roles of oxi‑
dants, remain to be elucidated.
In regard to the role of inflammatory mediators 
in asthma pathophysiology and in glucocorticoid 
resistance, elevated Gr number and diminished Gr 
binding affinity have been described in asthmatic 
patients (S h e r  et al., 1994), as well as in PBMcs 
from healthy donors after treatment with Il‑2 and 
Il‑4 (k a m  et al., 1993). the underlying mechanism 
of alterations in Gr binding parameters has not yet 
been described. However, an increasing number 
of studies indicate that cytokines initiate the pro‑
duction of reactive oxygen and nitrogen species in 
various cell types (o h b a  et al., 1994; B o h l e r  et 
al., 2000). this cross‑talk  between cytokines and 
reactive species supports the assumption that a reac‑
tive species‑mediated mechanism might be associ‑
ated with the changes in Gr binding characteristics 
observed after treatment with cytokines.
In our study, the Gr level in PBMcs was also 
examined by Western blot analysis. the observed 
SIn‑1– and H2o2‑induced changes in the Gr pro‑
tein level, measured by Western blot, were parallel 
to those in the number of dexamethasone‑binding 
sites determined by radioligand binding assay. Being 
based on the use of antibodies that recognize epi‑
topes in denatured polypeptides, the Western blot 
method provided the means to detect Gr protein 
regardless of its hormone‑binding activity. In con‑
trast, only receptor molecules that are unoccupied 
by the hormone can be detected by radioligand 
binding assay. thus, immunoblotting is a way to 
assess the Gr protein level that results from the bal‑
ance between receptor synthesis and degradation, 
whereas binding studies disclose only functional 
receptor molecules that are able to bind ligand. 
Any discrepancy between results of the two meth‑
ods suggests that the mechanisms regulating the 
receptor’s binding activity are implicated. In our 
study, however, treatment of mononuclear cells with 
oxidative agents produced changes in the number of 
functional Gr molecules, which can be explained by 
similar changes in the Gr protein level, suggesting 
that the agents applied did not affect regulation of 
Gr binding activity. this suggestion seemingly con‑
tradicts our finding that H2o2 provoked a significant 
decrease in the receptor’s affinity for the hormone, 
as well as the well documented fact that H2o2 can 
inactivate steroid‑binding activity of the Gr, pro‑
moting formation of intramolecular disulfide bonds 
(S i l v a  and c i d l o w s k i , 1989; M e s h i n c h i 
et al., 1990). However, inasmuch as treatment of 
PBMcs with H2o2 was herein shown to lead to a 
considerable increase in the receptor protein level, 
it can be assumed that this increase is large enough 
to overcome the peroxide‑induced diminishment of 
the receptor’s hormone‑binding activity. 
It is well known that a cell’s sensitivity to glu‑
cocorticoids is directly determined by the level and 
molecular nature of the Gr therein, and that human 
tissues harbor multiple isoforms of this protein, 
some of which (e.g., Grα and Grβ) are the products 
of alternative splicing of the Gr gene (o a k l e y  et 
al., 1996), while others are generated from a single 
Gr mrnA species by alternative translation ini‑
tiation (l u  and c i d l o w s k i , 2005).  one of the 
antibodies used in this study (Ab1) was previously 
shown to recognize some of these isoforms (l u 
and c i d l o w s k i , 2005) and is therefore suitable 
for investigating treatment‑specific differences in 
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molecular properties of the Gr in PBMcs. It was 
found that H2o2 treatment specifically modulated 
the pattern of immunospecific Gr bands, consider‑
ably increasing intensity of the 60‑kda species over 
that of the corresponding band in untreated cells of 
healthy volunteers. Interestingly, a very similar pat‑
tern of immunospecific bands was obtained from 
PBMcs of pediatric patients suffering from moder‑
ate asthma, while mild asthmatics presented a pat‑
tern resembling that of healthy subjects (P e r i š i ć 
et al., unpublished data). Since at this moment the 
precise cellular roles and intracellular localization of 
different Gr isoforms are far from being elucidated, 
it is premature to speculate on the possible biological 
significance of this finding. Besides, it should be first 
established whether the 60‑kda species represents 
an isoform or a proteolytic product of the Gr.
It is demonstrated in this paper that the altera‑
tions of Gr binding properties and the protein 
expression pattern induced by H2o2 treatment of 
PBMcs from healthy donors are very similar to 
those registered in PBMcs of moderate asthmatic 
patients in comparison with mild asthmatics and 
healthy subjects. In contrast, treatment with other 
oxidants produced different effects or had no influ‑
ence on Gr binding activity and the protein expres‑
sion pattern. It follows that this study provides pre‑
liminary data suggesting that functional alterations 
of the Gr associated with moderate asthma may be 
mediated by redox mechanisms relying on the oxi‑
dative and regulatory actions of H2o2. 
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Познато је да су патогенеза и напредовање 
хронич­не астме повезани са функ­ционал­ним 
променама гл­ук­ок­ортик­оидног рецептора (Gr) 
и дуготрајном инфл­амацијом дисајних путева, 
ч­ији су медијатори реак­тивне врсте к­исеоник­а 
и азота. У овом раду тестирал­и смо хипотезу да 
функ­ционал­не промене Gr у астми настају к­ао 
посл­едица дел­овања ок­сиданата. У том циљу 
спровел­и смо серију ex vivo третмана мононук­л­е‑
арних ћел­ија периферне к­рви здравих донора 
ок­сидујућим агенсима (3‑морфол­иносиднони‑
мином, SIn‑1; S‑нитрозо‑n‑ацетил­‑пеницил­ами‑
ном, SnAP; и водоник­ перок­сидом, H2о2) и упо‑
редил­и настал­е модифик­ације Gr са онима к­оје 
су раније запажене к­од астматич­них пацијената. 
резул­тати су пок­азал­и да је третман периферних 
л­имфоцита водоник­ перок­сидом изазвао повећа‑
ње к­онцентрације Gr протеина, к­оје је бил­о пра‑
ћено повећањем броја места везивања хормона и 
смањењем афинитета рецептора према хормону. 
Промене индук­оване водоник­ перок­сидом, ук­љу‑
ч­ујући и к­арак­теристич­ну ек­спресију изоформи 
Gr протеина, бил­е су врл­о сл­ич­не променама 
к­оје су раније запажене у периферним л­имфо‑
цитима пацијената обол­ел­их од средње тешк­ог 
обл­ик­а астме, ал­и не и к­од бл­агих астматич­ара 
и здравих донора. Третман другим примењеним 
ок­сидантима произвео је другач­ије ефек­те, ил­и 
није имао утицаја на Gr. Према томе, ова студија 
је дал­а прел­иминарне податк­е к­оји ук­азују да су 
функ­ционал­не промене Gr повезане са средње 
тешк­ом астмом вероватно посредоване редок­с 
механизмима к­оји се заснивају на ок­сидативној 
и регул­аторној ул­ози водоник­ перок­сида.
